Is Perspective Therapeutics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NYSEMKT: CATX) stock is to Strong Buy CATX stock.
Out of 3 analysts, 2 (66.67%) are recommending CATX as a Strong Buy, 1 (33.33%) are recommending CATX as a Buy, 0 (0%) are recommending CATX as a Hold, 0 (0%) are recommending CATX as a Sell, and 0 (0%) are recommending CATX as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year CATX price target, the average CATX price target is $1.53, with the highest CATX stock price forecast at $1.70 and the lowest CATX stock price forecast at $1.40.
On average, Wall Street analysts predict that Perspective Therapeutics's share price could reach $1.53 by Apr 9, 2025. The average Perspective Therapeutics stock price prediction forecasts a potential upside of 0.2% from the current CATX share price of $1.53.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.